Indivior Pharmaceuticals, Inc. INDV Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's deferred tax assets?
- Indivior Pharmaceuticals, Inc. (INDV) reported deferred tax assets of $296M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's deferred tax assets changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's deferred tax assets increased by 6.1% year-over-year, from $279M to $296M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's deferred tax assets?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's deferred tax assets has grown at a 6.3% compound annual growth rate (CAGR), from $286M to $323M.
- What does deferred tax assets mean?
- Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.